Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cheribundi is a functional beverage company specializing in tart cherry-based products designed for athletic recovery and wellness. The company's products are formulated using a proprietary extraction process that retains the natural phytonutrients, specifically anthocyanins and melatonin, found in Montmorency tart cherries. Cheribundi's portfolio includes performance juices, concentrates, and wellness shots targeted at reducing inflammation and improving sleep quality. The brand is a staple in professional and collegiate sports, serving over 450 elite athletic teams across the NFL, NBA, MLB, and NCAA. Originally founded as CherryPharm, the company's foundations are rooted in scientific research conducted at Cornell University regarding the anti-inflammatory properties of tart cherries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cheribundi.